DiscoverPartners in Digital HealthWhy Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA
Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA

Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA

Update: 2025-09-22
Share

Description

Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA

  • Christiane Wirrig, PhD | Customer Success Manager, Spherity
  • David Kessler | Co-owner and President, Legisym

Discussion on the importance of standardization in order to digitalize the U.S. pharmaceutical supply chain as motivated by the Drug Supply Chain Security Act (DSCSA).

Key topics

  • What is DSCSA?
  • What does FDA’s Stabilization Period mean?
  • Why do technology standards matter and how are they being implemented, i.e. interoperability through standards?
  • Focus on standardization, due diligence in the context of DSCSA-regulated digitally managed pharma supply chain
  • 2023 readiness in relation to stabilization period until 2024
  • Inspections will keep happening
  • ATP is mandatory, authentication & authorization
  • Data security
Comments 
In Channel
AI and Reimbursement

AI and Reimbursement

2025-10-0642:24

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA

Why Industry-Wide Standards Matter In Fulfilling the Intent of DSCSA